The importance of dissolution for orally inhaled drug products: pharmaceutical, regulatory, and clinical considerations

Karin Somby; Martin Hingle; Ivana Tomic; Ben Forbes

doi:10.1080/17425247.2023.2205636

The importance of dissolution for orally inhaled drug products: pharmaceutical, regulatory, and clinical considerations

Expert Opin Drug Deliv. 2023 Jul-Dec;20(8):1033-1036. doi: 10.1080/17425247.2023.2205636. Epub 2023 Apr 24.

Authors

Karin Somby^{1

2}, Martin Hingle², Ivana Tomic², Ben Forbes¹

Affiliations

¹ King's College London, Institute of Pharmaceutical Science, London, UK.
² Novartis Pharma AG, Basel, Switzerland.

PMID: 37078605
DOI: 10.1080/17425247.2023.2205636

No abstract available

Keywords: In vitro-in vivo correlation (IVIVC); dissolution; inhalation biopharmaceutics classification system (iBCS); physiologically based biopharmaceutics modeling (PBBM); respiratory.

Publication types

Editorial

MeSH terms

Administration, Oral
Biological Availability
Biopharmaceutics*
Drug Liberation
Models, Biological*
Pharmaceutical Preparations
Solubility
Therapeutic Equivalency

Substances

Pharmaceutical Preparations